Loading clinical trials...
Loading clinical trials...
A Phase II, Randomized, Double-Blind, Vehicle Controlled Study of the Efficacy, Safety, and Tolerability of B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis
Conditions
Interventions
B244
Vehicle
Locations
56
United States
Cahaba Dermatology
Birmingham, Alabama, United States
Elite Clinical Studies, LLC
Phoenix, Arizona, United States
Cognitive Clinical Trials
Scottsdale, Arizona, United States
Dermatology Trial Associates
Bryant, Arkansas, United States
Applied Research Center of Arkansas, Inc
Little Rock, Arkansas, United States
Core Healthcare Group
Cerritos, California, United States
Start Date
June 24, 2020
Primary Completion Date
December 10, 2021
Completion Date
January 7, 2022
Last Updated
January 28, 2025
NCT06461897
NCT07262983
NCT06389136
NCT06342713
NCT07290803
NCT07223697
Lead Sponsor
AOBiome LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions